Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Chloroquine phosphate - Generic Drug Details

« Back to Dashboard

What are the generic sources for chloroquine phosphate and what is the scope of chloroquine phosphate patent protection?

Chloroquine phosphate
is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Teva, Ipca Labs Ltd, Natco Pharma Ltd, Impax Labs, Md Pharm, Watson Labs, Hikma Pharms Llc, and Purepac Pharm, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for chloroquine phosphate. Seven suppliers are listed for this compound.

Summary for Generic Name: chloroquine phosphate

Drug Master File Entries: see list19
Suppliers / Packagers: see list7
Bulk Api Vendors: see list94
Clinical Trials: see list446
Patent Applications: see list7,156
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:chloroquine phosphate at DailyMed

Pharmacology for Ingredient: chloroquine phosphate

Drug ClassAntimalarial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ipca Labs Ltd
chloroquine phosphate
TABLET;ORAL090610-001Dec 3, 2009AARXNoNo► Subscribe► Subscribe
Ipca Labs Ltd
chloroquine phosphate
TABLET;ORAL090249-001Dec 3, 2009AARXNoNo► Subscribe► Subscribe
Md Pharm
chloroquine phosphate
TABLET;ORAL087228-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Hikma Pharms Llc
chloroquine phosphate
TABLET;ORAL083082-001Approved Prior to Jan 1, 1982AARXNoYes► Subscribe► Subscribe
chloroquine phosphate
TABLET;ORAL087504-001Jan 13, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus